[go: up one dir, main page]

NO960268L - New dialkoxypyridinylbenzimidazole derivatives - Google Patents

New dialkoxypyridinylbenzimidazole derivatives

Info

Publication number
NO960268L
NO960268L NO960268A NO960268A NO960268L NO 960268 L NO960268 L NO 960268L NO 960268 A NO960268 A NO 960268A NO 960268 A NO960268 A NO 960268A NO 960268 L NO960268 L NO 960268L
Authority
NO
Norway
Prior art keywords
compounds
methyl
new
dialkoxypyridinylbenzimidazole
derivatives
Prior art date
Application number
NO960268A
Other languages
Norwegian (no)
Other versions
NO960268D0 (en
Inventor
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Per Oskar Sverker Von Unge
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO960268D0 publication Critical patent/NO960268D0/en
Publication of NO960268L publication Critical patent/NO960268L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nye optisk rene forbindelser, dvs de enantiomere enkeltforbindelsene (+)-5- karbometoksy-6-metyl-2-[[(3,4-dimetoksy-2-pyridinyl)metyl]sulfmyl]-l-[mandel- oyloksymetyl]-! H-benzimidazol og (-)-5-karbometoksy-6-metyl-2-[[(3,4-dimetoksy-2- pyridinyl)metyl]sulfinyl]-1 -[mandeloyloksymetyl]-1 H-benzimidazol eller et terapeutisk akseptabelt salt derav, slik som Na+, Mg2+, Li+, K+, Ca2+og N+(R)4 salter, hvor R er en alkylgruppe med 1-4 karbonatomer, fremgangsmåter for fremstilling derav og farma- søytiske preparater inneholdende forbindelsene som aktive bestanddeler, anvendelse av forbindelsene i farmasøytiske preparater samt mellomprodukter oppnådd ved frem- ' stilling av forbindelsene.New optically pure compounds, i.e. the enantiomeric single compounds (+) - 5-carbomethoxy-6-methyl-2 - [[(3,4-dimethoxy-2-pyridinyl) methyl] sulfmyl] -1- [almond oyloxymethyl] -! H-benzimidazole and (-) - 5-carbomethoxy-6-methyl-2 - [[(3,4-dimethoxy-2-pyridinyl) methyl] sulfinyl] -1 - [mandeloyloxymethyl] -1H-benzimidazole or a therapeutically acceptable salts thereof, such as Na +, Mg 2+, Li +, K +, Ca 2+ and N + (R) 4 salts, wherein R is an alkyl group of 1-4 carbon atoms, processes for their preparation and pharmaceutical preparations containing the compounds as active ingredients, use of the compounds in pharmaceutical preparations as well as intermediates obtained by the preparation of the compounds.

NO960268A 1994-05-27 1996-01-23 New dialkoxypyridinylbenzimidazole derivatives NO960268L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25617194A 1994-05-27 1994-05-27
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (en) 1994-05-27 1995-05-11 Novel dialkoxy-pyridinyl-benzimidazole derivatives

Publications (2)

Publication Number Publication Date
NO960268D0 NO960268D0 (en) 1996-01-23
NO960268L true NO960268L (en) 1996-01-23

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960268A NO960268L (en) 1994-05-27 1996-01-23 New dialkoxypyridinylbenzimidazole derivatives

Country Status (18)

Country Link
EP (1) EP0712401A1 (en)
JP (1) JPH09504557A (en)
CN (1) CN1128997A (en)
AU (1) AU2633095A (en)
BR (1) BR9506235A (en)
CA (1) CA2166988A1 (en)
CZ (1) CZ24396A3 (en)
EE (1) EE9600011A (en)
FI (1) FI960367A0 (en)
HU (1) HU9600005D0 (en)
IL (1) IL113604A0 (en)
IS (1) IS4321A (en)
MA (1) MA23563A1 (en)
NO (1) NO960268L (en)
PL (1) PL312692A1 (en)
TN (1) TNSN95062A1 (en)
WO (1) WO1995032959A1 (en)
ZA (1) ZA954125B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
JP4610086B2 (en) 1998-11-18 2011-01-12 アストラゼネカ・アクチエボラーグ Improved chemical methods and pharmaceutical formulations
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
CN101980700A (en) 2008-02-20 2011-02-23 密苏里大学董事会 Compositions comprising a combination of omeprazole and lansoprazole and a buffer and methods of use thereof
CN102209529A (en) 2008-09-09 2011-10-05 阿斯利康(瑞典)有限公司 Method for delivering a pharmaceutical composition to patient in need thereof
SG176724A1 (en) 2009-06-25 2012-01-30 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US9539214B2 (en) 2011-12-28 2017-01-10 Pozen Inc. Compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0593463B1 (en) * 1990-06-20 1999-09-15 Astra Aktiebolag Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
DE4035455A1 (en) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab ENANTIOMER SEPARATION

Also Published As

Publication number Publication date
IL113604A0 (en) 1995-08-31
CZ24396A3 (en) 1996-06-12
EP0712401A1 (en) 1996-05-22
MA23563A1 (en) 1995-12-31
NO960268D0 (en) 1996-01-23
BR9506235A (en) 1997-08-12
WO1995032959A1 (en) 1995-12-07
IS4321A (en) 1996-01-17
ZA954125B (en) 1995-11-27
AU2633095A (en) 1995-12-21
PL312692A1 (en) 1996-05-13
JPH09504557A (en) 1997-05-06
CA2166988A1 (en) 1995-12-07
FI960367L (en) 1996-01-26
HU9600005D0 (en) 1996-03-28
TNSN95062A1 (en) 1996-02-06
FI960367A0 (en) 1996-01-26
EE9600011A (en) 1996-04-15
CN1128997A (en) 1996-08-14

Similar Documents

Publication Publication Date Title
MY121192A (en) New compounds.
NO960268L (en) New dialkoxypyridinylbenzimidazole derivatives
NO160204C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKALISTS OF 5-METOXY-2 (((4-METOXY-3,5-DIMETHYL-2-PYRIDINYL) -METHYL) -SULPHINYL) -1H-BENZIMIDAZOLE.
NO166126C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLONCARBOXYLIC ACID DERIVATIVES.
ES2108717T3 (en) DERIVATIVES OF THE TETRAHIDROPIRROLO (1,2-A) PIRAZINA-4-ESPIRO-3'-PIRROLIDINA, PROCEDURES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IL57324A (en) 3-substituted-6-alkanoylamino-1,3,5-triazine-2,4-diones,process for their preparation and pharmaceutical compositions containing them
NO178338C (en) Analogous Process for Preparing a Therapeutically Active Benzimidazole Compound and Intermediate
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
AU7817087A (en) 2-(thio-linked)-pyridine-5-(4,5-dihydro-2-oxazolyl)-(thieno( 2,3-d)-imidazoles and -benzimidazoles), a process for their preparation, and their use
MX9806229A (en) BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5'alpha'-REDUCTASES INHIBITORS.
ES8100263A1 (en) and analogy processes for the manufacture thereof.
NO960267L (en) Newly substituted benzimidazoles
AU545254B2 (en) Benzo (4,5) pyrano (2,3c) pyrroles, processes for their preparation and pharmaceutical preparations containing same
JO1871B1 (en) Novel substituted benzimidazoles
AU1390692A (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
JO1870B1 (en) Novel dialkoxy - pyridinyl-benzimidazole derivatives
EP0192393A3 (en) Alkylaminofuranone derivatives
FI893570A0 (en) Process for the preparation of 1H-imidazo [1,2-b] pyrazole derivatives useful as medicaments
AU617849B2 (en) New benzopyrrolidinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
DE69000806D1 (en) INDOL DERIVATIVES.
CS725786A2 (en) Zpusob vyroby novych 2 (2 thienyl)imidazo (4,5 c)pyridinovych derivatu
DK210387A (en) HETEROCYCLIC RELATIONS AND PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE
JO1660B1 (en) therapeutically active chloro substituted benzimidazoles process for their preparation as well as their use